TipRanks Cyber Monday Sale
- Claim 60% off TipRanks Premium for data-backed insights and research tools you need to invest with confidence.
- Subscribe to TipRanks' Smart Investor Picks and see our data in action through our high-performing model portfolio - now also 60% off
Monash IVF Group Ltd ( (AU:MVF) ) has shared an announcement.
Monash IVF Group Ltd has appointed Dr. Dwayne Crombie as an Independent Non-Executive Director, effective from 24 November 2025. Dr. Crombie brings extensive experience from his career in healthcare across New Zealand and Australia, including senior roles at Bupa and governance positions in healthcare organizations. His appointment is expected to enhance the strategic capabilities of the Monash IVF Group Board, potentially impacting the company’s operations and positioning within the healthcare industry.
The most recent analyst rating on (AU:MVF) stock is a Hold with a A$1.00 price target. To see the full list of analyst forecasts on Monash IVF Group Ltd stock, see the AU:MVF Stock Forecast page.
More about Monash IVF Group Ltd
Monash IVF Group Ltd is a leading provider of assisted reproductive services and specialist women’s imaging and diagnostic services, operating in Australia, Singapore, Indonesia, and Malaysia.
Average Trading Volume: 2,436,967
Technical Sentiment Signal: Sell
Current Market Cap: A$268.8M
See more insights into MVF stock on TipRanks’ Stock Analysis page.